The Caithness Business Index has posted the following article:

First Oral Antiviral For Covid-19, Lagevrio (molnupiravir), Approved By MHRA

The antiviral was found to be safe and effective following a stringent review of the available evidence. The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency (MHRA) announced on Thursday 4 November 2021. [Read Full Article]